Medicare Enrolled
Dr. Thomas McMinn, MD
Cardiovascular Disease · Austin, TX
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McMinn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McMinn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McMinn
Dr. Thomas McMinn is a cardiovascular disease specialist in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. McMinn performed 2,021 Medicare services across 1,783 unique beneficiaries.
Between the years covered by Open Payments, Dr. McMinn received a total of $35,244 from 30 pharmaceutical and/or device companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McMinn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 49% volume in TX
$35,244 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,021
Medicare services
Top 49% in TX for cardiovascular disease
1,783
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~101 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
396 | $93 | $206 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
377 | $11 | $60 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
144 | $61 | $141 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
124 | $135 | $278 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
112 | $2 | $12 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
91 | $79 | $334 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
71 | $5 | $24 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
66 | $15 | $70 |
| Cardiac catheterization | 60 | $178 | $983 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
56 | $89 | $202 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
47 | $10 | $39 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
41 | $13 | $59 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $105 | $320 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
37 | $79 | $390 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
37 | $6 | $27 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $100 | $268 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
28 | $9 | $38 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
27 | $424 | $1,804 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
27 | $54 | $523 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 26 | $274 | $1,232 |
| New patient office visit, complex (60-74 min) | 26 | $160 | $398 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
22 | $4 | $17 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
22 | $16 | $79 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
21 | $10 | $45 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
18 | $19 | $83 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 18 | $221 | $1,106 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
18 | $84 | $205 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
15 | $52 | $205 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
13 | $9 | $47 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
11 | $66 | $278 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
16.7% medium
71.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,244
Total received (2018-2024)
Avg $5,035/year across 7 years
Top 13% in TX for cardiovascular disease
30
Companies
259
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,260 (88.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,971 (11.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,098
2023
$588
2022
$462
2021
$876
2020
$5,194
2019
$12,473
2018
$11,553
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$32,136
ABIOMED
$939
Actelion Pharmaceuticals US, Inc.
$410
Medtronic, Inc.
$260
Novartis Pharmaceuticals Corporation
$175
BIOTRONIK INC.
$131
CVRx, Inc.
$126
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$111
Acist Medical Systems, Inc.
$109
Novo Nordisk Inc
$76
Amgen Inc.
$74
Boston Scientific Corporation
$68
Terumo Medical Corporation
$67
PFIZER INC.
$66
ShockWave Medical, Inc
$59
Impulse Dynamics (USA) Inc.
$55
Alnylam Pharmaceuticals Inc.
$46
E.R. Squibb & Sons, L.L.C.
$46
AstraZeneca Pharmaceuticals LP
$43
Allergan Inc.
$37
Baxter Healthcare
$37
Regeneron Healthcare Solutions, Inc.
$33
Medtronic Vascular, Inc.
$24
ATRICURE, INC.
$24
Shockwave Medical, Inc
$24
Janssen Pharmaceuticals, Inc
$16
Chiesi USA, Inc.
$15
CHIESI USA, INC.
$13
Kiniksa Pharmaceuticals International, plc
$13
Otsuka America Pharmaceutical, Inc.
$11
Top 3 companies account for 95.0% of total payments
Associated products mentioned in payments ›
AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · AMPLATZER TALISMAN · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · Accent Pacemaker · Arcalyst · Asahi Fielder coronary guide wire · BRILINTA · BYSTOLIC · BYVALSON · Barostim Neo System · CAMZYOS · CARDIOMEMS · CLEVIPREX · COREVALVE EVOLUT R · COROFLOW · CVI Systems · CoreValve Evolut · Corlanor · DRAGONFLY OPSTAR · Dragonfly OCT · ELIQUIS · ENTRESTO · FARXIGA · Glidesheath · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hi-Torque Command guide wire · Hillrom - Carnation Ambulatory Monitor · IN.PACT Admiral · Impella · KENGREAL · LEQVIO · Legacy · LifeVest · MetaCross · Misago · ONPATTRO · OPSUMIT · OPTIMIZER · OPTIS · Optis Coronary Imaging System · Ozempic · PCI Optimization · PRALUENT · PRESSUREWIRE · Perclose ProGlide suture mediated closure system · PressureWire FFR · Repatha · SAMSCA · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · ULTREON · UPTRAVI · VYNDAQEL · Vascular Lithotripsy · WATCHMAN · WATCHMAN Access System · XARELTO · Xience Sierra Coronary Stent · Xience V coronary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (89%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $1,744 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
96
Per 100K population
7.3
County median income
$97,169
Nearest hospital
AUSTIN STATE HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McMinn is an electrophysiology & cardiac specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 13% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McMinn experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McMinn performed 396 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McMinn receive payments from pharmaceutical companies?
Yes. Dr. McMinn received a total of $35,244 from 30 companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McMinn's costs compare to other cardiologists in Austin?
Dr. McMinn's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McMinn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Austin
Browse cardiologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology